Nancy Barone Kribbs, Ph.D.

Nancy Barone Kribbs, Ph.D. has extensive experience in regulatory affairs within the pharmaceutical industry. Nancy Barone currently holds the role of Senior Vice President, Global Regulatory Affairs at Myrtelle since August 2021. Prior to this, they served as Vice President Regulatory Affairs at Aruvant from June 2020 to July 2021.

From November 2017 to October 2019, Nancy worked as the Vice President, Global Regulatory Affairs, Gene Therapy at PTC Therapeutics, Inc. & Agilis Biotherapeutics (acquired by PTC). Before that, they held the position of Executive Director Global Regulatory Affairs at AveXis, Inc. from March 2017 to October 2017.

In previous roles, Nancy served as the Executive Director, Global Regulatory Affairs at Ophthotech from March 2016 to March 2017 and as the Director/Global Regulatory Team Leader at Bristol-Myers Squibb from April 2012 to March 2016. Nancy Barone also worked as the Senior Director, Global Regulatory Affairs at sanofi-aventis from February 1999 to April 2012.

Nancy's career in the pharmaceutical industry began as a Medical Writer at Cephalon from 1996 to 1999 and as a Clinical Writer at BioPharm from 1995 to 1996. Nancy Barone also has research experience as a Research Assistant Professor in Psychiatry at the University of Pennsylvania School of Medicine from 1987 to 1994.

Nancy Barone Kribbs, Ph.D. obtained their Bachelor of Science (B.S.) degree in Psychology from Xavier University. Nancy Barone later pursued further education at The University of Toledo, where they completed their Master of Science (M.S.) and Ph.D. in Experimental Psychology.